In 2011, the International Breast Cancer Association classified breast cancer into four subtypes based on the expression of three tumor markers: estrogen receptor (ER), progesterone receptor (PR), Ki-67, and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene PGR and neoplasm.